kaia is a digital therapeutics company focused on artificial intelligence.Biofourmis provide patients with affordable, effective health management solutions that personalizes and improves their experience and quality of care. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. Atomwise has launched more than 50 discovery projects in partnership with the world's top research companies and universities. Believers in the power of digital therapeutics think that one day prescriptions for apps will be as widespread as they are for pills. CDD offers a web-based database solution for managing drug discovery data, primarily around small molecules and associated bio-assay data.Oviva offers a suite of clinical programmes developed to address diet-related conditions at scale. The Company was founded by PureTech Health (PRTC.L). The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.To view the original version on The Express Wire visit Backed by leading life sciences venture capital groups and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families. In this report, Business Insider Intelligence will explore the drivers lighting a fire under the DTx market, identify the leading DTx market players, and unpack the varied ways vendors reach their intended audiences. Autolus is a leader in T cell programming technologies and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both hematological cancers and solid tumors.BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases.Propeller Health is a leading digital therapeutics company dedicated to the development and commercialization of measurably better medicines. Our focus is on the following: Cardiovascular, Renal and Metabolism; Oncology; Respiratory, Inflammation and Autoimmunity; Infection and Vaccines; and Neuroscience.Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. We focus on creating new treatment options for patients with diabetes to manage their disease and avoid its complications; At Genentech we're focused on exploring new antibacterial targets, antiviral targets and new mechanisms for killing pathogens, as well as new ways to deliver therapeutics to the site of infection that are both more efficient at pathogen elimination and less toxic to the host. Pear's second product, reSET-O, for the treatment of Opioid Use Disorder, received marketing authorization from the FDA in December 2018.iBio is a biotechnology company and a full-service biologics CDMO equipped to take you from pre-clinical development through regulatory approval, to commercial product launch. Our aim is to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it. They were established in October 2017 and are based in Toronto, Canada. That’s why we focused on deep learning.Quit Genius is an evidence-based, easy to access, app that is designed to provide smokers with the behavioural support they need to quit smoking. Quit Genius is an evidence-based, easy to access, app that is designed to provide smokers with the behavioural support they need to quit smoking.
Top ranked companies founded since 2015 for keyword search: In addition, our research efforts are focused on ways of combatting resistance mechanisms to existing drugs; We’re currently focused on diseases of the eye that cause significant vision loss such as wet age-related macular degeneration, geographic atrophy, diabetic macular edema and glaucoma.Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Major companies in the medtech space — including Philips, Google and ResMed — are among those joining the Consumer Technology Association’s new digital therapeutics … For the period 2015-2020, this study provides the Digital Therapeutics sales, revenue and market share for each player covered in this report.3.1 Global Digital Therapeutics Sales and Market Share by Manufacturer (2019-2020)3.2 Global Digital Therapeutics Revenue and Market Share by Manufacturer (2019-2020)3.3 Digital Therapeutics Market Concentration Rates3.3.1 Top 3 Digital Therapeutics Manufacturer Market Share in 20203.3.2 Top 6 Digital Therapeutics Manufacturer Market Share in 20204.1 Global Digital Therapeutics Sales, Revenue and Market Share by Regions4.1.1 Global Digital Therapeutics Sales and Market Share by Regions (2014-2019)4.1.2 Global Digital Therapeutics Revenue and Market Share by Regions (2014-2019)4.2 North America Digital Therapeutics Sales and Growth Rate (2014-2019)4.3 Europe Digital Therapeutics Sales and Growth Rate (2014-2019)4.4 Asia-Pacific Digital Therapeutics Sales and Growth Rate (2014-2019)4.6 South America Digital Therapeutics Sales and Growth Rate (2014-2019)4.6 Middle East and Africa Digital Therapeutics Sales and Growth Rate (2014-2019)5.1 Global Digital Therapeutics Sales, Revenue and Growth Rate (2020-2025)5.2 Digital Therapeutics Market Forecast by Regions (2020-2025)5.3 Digital Therapeutics Market Forecast by Type (2020-2025)5.3.1 Global Digital Therapeutics Sales Forecast by Type (2020-2025)5.3.2 Global Digital Therapeutics Market Share Forecast by Type (2020-2025)5.4 Digital Therapeutics Market Forecast by Application (2020-2025)5.4.1 Global Digital Therapeutics Sales Forecast by Application (2020-2025)5.4.2 Global Digital Therapeutics Market Share Forecast by Application (2020-2025)The next part also sheds light on the gap between supply and consumption.